Vital signs at the start of high-flow nasal cannula oxygen therapy
| Mean (BCA 95% CI) | Missing, n (%) | |
| Heart rate | 95 (91 to 99) | 10 (10.4 %) |
| Mean arterial pressure | 92.90 (89.42 to 96.53) | 10 (10.4%) |
| Respiratory rate | 20 (19 to 22) | 12 (12.5%) |
| SpO2 | 94 (93 to 94) | 10 (10.4%) |
| pH | 7.41 (7.40 to 7.43) | 24 (25.0%) |
| pCO2 | 39.6 (38.2 to 41.1) | 24 (25.0%) |
| pO2 | 72.7 (69.4 to 76.8) | 24 (25.0%) |
| HCO3 | 24.8 (23.9 to 25.6) | 24 (25.0%) |
| BE | 0.12 (−0.90 to 1.04) | 24 (25.0%) |
| Std. HCO3 | 24.8 (24.0 to 25.5) | 28 (29.2%) |
| Saturation | 94% (93 to 94) | 25 (26.0%) |
| P/F ratio | 152.7 (139.8 to 166.0) | 28 (29.2%) |
| CRP | 163 (144 to 185) | 9 (9.4%) |
| Leukocyte count | 13.0 (11.82 to 14.21) | 7 (7.3%) |
This table shows the vital parameters, arterial blood gas values and laboratory investigations just before the start of high-flow nasal cannula oxygen therapy at the intermediate care unit.
CRP, C reactive protein; BE, base excess; P/F, PaO2/FiO2.